Cargando…

Prognostic role of Toll-like receptors in cancer: a meta-analysis

BACKGROUND: Recent studies have shown that Toll-like receptors (TLRs) may be associated with cancers. The aim of this meta-analysis is to summarize the predicting role of TLRs for survival in patients with a variety of carcinomas. MATERIALS AND METHODS: Eligible studies were identified and assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qingwen, Zhang, Xiankai, Xiao, Tingting, Pan, Chenhua, Liu, Xing, Zhao, Yulan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071644/
https://www.ncbi.nlm.nih.gov/pubmed/30104878
http://dx.doi.org/10.2147/TCRM.S171341
_version_ 1783343908329095168
author Wang, Qingwen
Zhang, Xiankai
Xiao, Tingting
Pan, Chenhua
Liu, Xing
Zhao, Yulan
author_facet Wang, Qingwen
Zhang, Xiankai
Xiao, Tingting
Pan, Chenhua
Liu, Xing
Zhao, Yulan
author_sort Wang, Qingwen
collection PubMed
description BACKGROUND: Recent studies have shown that Toll-like receptors (TLRs) may be associated with cancers. The aim of this meta-analysis is to summarize the predicting role of TLRs for survival in patients with a variety of carcinomas. MATERIALS AND METHODS: Eligible studies were identified and assessed for quality through multiple search strategies. We collected data from studies investigating the relationship between the expression level of TLRs and survival in cancer patients. Studies were pooled and combined hazard ratios (HRs) of TLRs for survival were analyzed. RESULTS: A total of 24 studies, including 2,812 patients with various cancers, were identified for the meta-analysis. Importantly, this meta-analysis showed that higher expression levels of TLR4 or TLR7 in tumor tissues could predict poorer survival, with the pooled HR being 1.29 (95% CI: 1.17, 1.42) and 1.71 (95% CI: 1.38, 2.12), respectively. However, higher expression of TLR9 had no significant association with outcome as HR was 0.84 (95% CI: 0.62, 1.115). Heterogeneity existed in TLR4 and TLR9 studies (P-value <0.001) but not in TLR7 studies (P-value >0.05). CONCLUSION: The expression level of TLR4 or TLR7 in cancerous tissue may have a prognosis value in patients with various cancers.
format Online
Article
Text
id pubmed-6071644
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-60716442018-08-13 Prognostic role of Toll-like receptors in cancer: a meta-analysis Wang, Qingwen Zhang, Xiankai Xiao, Tingting Pan, Chenhua Liu, Xing Zhao, Yulan Ther Clin Risk Manag Original Research BACKGROUND: Recent studies have shown that Toll-like receptors (TLRs) may be associated with cancers. The aim of this meta-analysis is to summarize the predicting role of TLRs for survival in patients with a variety of carcinomas. MATERIALS AND METHODS: Eligible studies were identified and assessed for quality through multiple search strategies. We collected data from studies investigating the relationship between the expression level of TLRs and survival in cancer patients. Studies were pooled and combined hazard ratios (HRs) of TLRs for survival were analyzed. RESULTS: A total of 24 studies, including 2,812 patients with various cancers, were identified for the meta-analysis. Importantly, this meta-analysis showed that higher expression levels of TLR4 or TLR7 in tumor tissues could predict poorer survival, with the pooled HR being 1.29 (95% CI: 1.17, 1.42) and 1.71 (95% CI: 1.38, 2.12), respectively. However, higher expression of TLR9 had no significant association with outcome as HR was 0.84 (95% CI: 0.62, 1.115). Heterogeneity existed in TLR4 and TLR9 studies (P-value <0.001) but not in TLR7 studies (P-value >0.05). CONCLUSION: The expression level of TLR4 or TLR7 in cancerous tissue may have a prognosis value in patients with various cancers. Dove Medical Press 2018-07-30 /pmc/articles/PMC6071644/ /pubmed/30104878 http://dx.doi.org/10.2147/TCRM.S171341 Text en © 2018 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Qingwen
Zhang, Xiankai
Xiao, Tingting
Pan, Chenhua
Liu, Xing
Zhao, Yulan
Prognostic role of Toll-like receptors in cancer: a meta-analysis
title Prognostic role of Toll-like receptors in cancer: a meta-analysis
title_full Prognostic role of Toll-like receptors in cancer: a meta-analysis
title_fullStr Prognostic role of Toll-like receptors in cancer: a meta-analysis
title_full_unstemmed Prognostic role of Toll-like receptors in cancer: a meta-analysis
title_short Prognostic role of Toll-like receptors in cancer: a meta-analysis
title_sort prognostic role of toll-like receptors in cancer: a meta-analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071644/
https://www.ncbi.nlm.nih.gov/pubmed/30104878
http://dx.doi.org/10.2147/TCRM.S171341
work_keys_str_mv AT wangqingwen prognosticroleoftolllikereceptorsincancerametaanalysis
AT zhangxiankai prognosticroleoftolllikereceptorsincancerametaanalysis
AT xiaotingting prognosticroleoftolllikereceptorsincancerametaanalysis
AT panchenhua prognosticroleoftolllikereceptorsincancerametaanalysis
AT liuxing prognosticroleoftolllikereceptorsincancerametaanalysis
AT zhaoyulan prognosticroleoftolllikereceptorsincancerametaanalysis